Impact of HER2-Low status in metastatic gastric cancer:A real-world retrospective cohort study
CONCLUSION: HER2-low metastatic gastric cancer has a higher rate of being low-grade than HER2-zero tumors. HER2-low metastatic gastric cancer is similar to HER2-zero in terms of chemotherapy response and survival.PMID:38354717 | DOI:10.1159/000537839
Source: Oncology - Category: Cancer & Oncology Authors: Olcun Umit Unal Seval Akay Gurkan Gul Murat Keser Birsen Gizem Ozamrak Dudu Solakoglu Kahraman Mihriban Erdogan Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Computers | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Statistics | Study